Surgery and chemoradiation in stage IIIA non-small cell lung cancer;Chirurgie et chimioradiothérapie dans les carcinomes bronchiques de stade IIIA

Cancer/Radiotherapie

Volumn 10, Issue 6-7, 2006, Pages 477-483

  Hennequin, C ^a   Girard, N ^b   Mornex, F ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Chemoradiation; Neoadjuvant treatment; Non small cell lung cancer; Radiotherapy; Surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; NAVELBINE; PACLITAXEL; VINBLASTINE; VINDESINE; ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CARCINOGENESIS; CLINICAL TRIAL; FEASIBILITY STUDY; HUMAN; INTERMETHOD COMPARISON; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; MEDIASTINUM CANCER; MULTIMODALITY CANCER THERAPY; ONCOLOGY; PRIORITY JOURNAL; SHORT SURVEY; THERAPY EFFECT; TREATMENT RESPONSE; LUNG TUMOR; METASTASIS; PATHOLOGY; REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 33750431000     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2006.09.001     Document Type: Short Survey

References (41)

1. Albain K.S., Rusch V.W., Crowley J.J., Rice T.W., Turrisi III A.T., Weick J.K., et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J. Clin. Oncol. 13 (1995) 1880-1892
2. Albain K., Swann R., Rusch V., Turrisi A., Shepherd F., Smith C., et al. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/Rt followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer (NSCLC): outcomes update of North American Intergroup 0139 (RTOG 9309). Proceed. Am. Soc. Clin. Oncol. 24 (2005) 7624s (abstract)
3. André F., Grunenwald D., Pignon J., Dujon A., Brouchet L., Moro D., et al. Survival of patients with resected N2 non small cell lung cancer: evidence of a subclassification and implications. J. Clin. Oncol. 18 (1999) 2981-2989
4. Riquet M., Assouad J., Bagan P., Foucault C., Le Pimpec Barthes F., Dujon A., et al. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Ann. Thorac. Surg. 79 (2005) 225-233
5. Bach P., Cramer L., Schrag D., Downey R., Gelfand S., and Begg C. The influence of hospital volume on survival after resection for lung cancer. N. Engl. J. Med. 345 (2001) 181-188
6. Betticher D.C., Hsu Schmitz S.F., Totsch M., Hansen E., Joss C., von Briel C., et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J. Clin. Oncol. 21 (2003) 1752-1759
7. Betticher D., Hsu Scmitz S., Tötsch M., Hansen E., Joss C., von Briel C., et al. Prognostic factors affecting long-term outcomes in patients with resected satge IIIA pN2 non-small cell lung cancer: 5-year follow-up of a phase II study. Br. J. Cancer 94 (2006) 1099-1106
8. Birim O., Kappetein A., van Klaveren R., and Bogers A. Prognostic factors in non-small cell lung cancer surgery. Eur. J. Surg. Oncol. 32 (2006) 12-23
9. Bueno R., Richards W., Swanson S., Jaklitsch M., Lukanich J., Mentzer S., et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann. Thorac. Surg. 70 (2000) 1826-1831
10. Choi N.C., Carey R.W., Daly W., Mathisen D., Wain J., Wright C., et al. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J. Clin. Oncol. 15 (1997) 712-722
11. Cyjon A., Nili M., Fink G., Kramer M.R., Fenig E., Sandbank J., et al. Advanced non-small cell lung cancer: induction chemotherapy and chemoradiation before operation. Ann. Thorac. Surg. 74 (2002) 342-347
12. DeCamp M.M., Rice T.W., Adelstein D.J., Chidel M.A., Rybicki L.A., Murthy S.C., et al. Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 126 (2003) 17-27
13. de Leyn P., and Decker G. Le traitement chirurgical du cancer bronchique non à petites cellules. Rev. Mal. Respir. 21 (2004) 971-982
14. Depierre A., Milleron B., Moro D., Chevret S., Braun D., Quoix E., et al. Phase III trial of neo-adjuvant chemotherapy in resectable stage I (except T1N0), II IIIA Non-small cell lung Cancer: the french experience. Proc. Am. Soc. Clin. Oncol. 18 (1999) 1465a (abstract)
15. Eberhardt W., Wilke H., Stamatis G., Stuschke M., Harstrick A., Menker H., et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. J. Clin. Oncol. 16 (1998) 622-634
16. Faber L.P., Kittle C.F., Warren W.H., Bonomi P.D., Taylor IV S.G., Reddy S., et al. Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer. Ann. Thorac. Surg. 47 (1989) 669-675 (discussion 676-7)
17. Fleck J., Camargo J., Godoy D., Teixeira P., Graga-Filho A., Barletta A., et al. Chemoradiation therapy alone versus chemotherapy alone as a neoadjuvant treatment for stage III non-small-cell lung cancer. Preliminary report of a phase III, randomized trial. Proc. Am. Soc. Clin. Oncol. 12 (1993) 1333 (abstract)
18. Grunenwald D.H., Andre F., Le Pechoux C., Girard P., Lamer C., Laplanche A., et al. Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 122 (2000) 796-802
19. Grunenwald D.H., and Albain K.S. The potential role of surgery after induction treatment. Semin. Radiat. Oncol. 14 (2004) 335-339
20. Hoekstra C.J., Stroobants S.G., Smit E.F., Vansteenkiste J., van Tinteren H., Postmus P.E., et al. Prognostic relevance of response evaluation using (18F)-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer. J. Clin. Oncol. 23 (2005) 8362-8370
21. Machtay M., Lee J.H., Stevenson J.P., Shrager J.B., Algazy K.M., Treat J., et al. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. J. Thorac. Cardiovasc. Surg. 127 (2004) 108-113
22. Mamon H.J., Yeap B.Y., Janne P.A., Reblando J., Shrager S., Jaklitsch M.T., et al. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. J. Clin. Oncol. 23 (2005) 1530-1537
23. Martin J., Ginsberg R.J., Venkatraman E.S., Bains M.S., Downey R.J., Korst R.J., et al. Long-term results of combined-modality therapy in resectable non-small-cell lung cancer. J. Clin. Oncol. 20 (2002) 1989-1995
24. Pisters K., Vallieres E., Bunn P., Crowley J., Ginsberg R., Ellis P., et al., Southwest Oncology Group. S9900: a phase III trial f surgery plus peoperative (preop) Paclitaxel/caroplatin (PC) chemotherapy in early stage non-small cell lung cancer NSCLC): preliminary results. Proceed. Am. Soc. Clin. Oncol. 24 (2005) 7624s (abstract)
25. Pottgen C., Levegrun S., Theegarten D., Marnitz S., Grehl S., Pink R., et al. Value of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy. Clin. Cancer Res. 12 (2006) 97-106
26. Robinson L.A., Wagner Jr. H., Ruckdeschel J.C., and American College of Chest Physicians. Treatment of stage IIIA non-small cell lung cancer. Chest 123 (2003) 202-220S
27. Rosell R., Gomez-Codina J., Camps C., Maestre J., Padille J., Canto A., et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non small cell lung cancer. N. Engl. J. Med. 330 (1994) 153-158
28. Roth J.A., Atkinson E.N., Fossella F., Komaki R., Ryan M.B., Putnam J.B., et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer 21 (1998) 1-6
29. Rusch V.W., Giroux D.J., Kraut M.J., Crowley J., Hazuka M., Johnson D., et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J. Thorac. Cardiovasc. Surg. 121 (2001) 472-483
30. Sculier J.P., Paesmans M., Ninane V., Giner V., Bureau G., Lafitte J.J., et al. Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party. Lung Cancer 2 (1998) 201-213
31. Semik M., Riesenbeck D., Linder A., Schmid C., Hoffknecht P., Heinecke A., et al., German Lung Cancer Cooperative Group. Preoperative chemotherapy with and without additional radiochemotherapy: benefit and risk for surgery of stage III non-small cell lung cancer. Eur. J. Cardiothorac. Surg. 26 (2004) 1205-1210
32. Sonett J.R., Suntharalingam M., Edelman M.J., Patel A.B., Gamliel Z., Doyle A., et al. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small cell lung cancer. Ann. Thorac. Surg. 78 (2004) 1200-1206
33. Stamatis G., Eberhardt W., Stuben G., Bildat S., Dahler O., and Hillejan L. Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term results. Ann. Thorac. Surg. 68 (1999) 1144-1149
34. Strauss G.M., Herndon J.E., Sherman D.D., Mathisen D.J., Carey R.W., Choi N.C., et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study. J. Clin. Oncol. 10 (1992) 1237-1244
35. Taylor N.A., Liao Z.X., Cox J.D., Stevens C., Roth J., Walsh G., et al. Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection. Int. J. Radiat. Oncol. Biol. Phys. 58 (2004) 204-212
36. Thomas M., Rube C., Semik M., von Eiff M., Freitag L., Macha H.N., et al. Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small-cell lung cancer. J. Clin. Oncol. 17 (1999) 1185
37. Trodella L., Granone P., Valente S., Margaritora S., Macis G., Cesario A., et al. Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging. Ann. Oncol. 15 (2004) 389-398
38. van Meerbeck J., Kramer G., van Schil P., Legrand C., Smit E., Schramel F., et al. A randomized trial of radical surgery (S) versus thorcacic radiotherapy (TRT) in patients with stage IIIA-N2 non-small cell lung cancer after response to induction chemotherapy (EORTC 08941). Proceed. Am. Soc. Clin. Oncol. 24 (2005) 7624s (abstract)
39. Vora S.A., Daly B.D., Blaszkowsky L., McGrath J.J., Bankoff M., Supran S., et al. High dose radiation therapy and chemotherapy as induction treatment for stage III nonsmall cell lung carcinoma. Cancer 89 (2000) 1946-1952
40. Weiden P.L., and Piantadosi S. Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small cell lung cancer. A phase 2 study of the LCSG. Chest 106 (1994) 344-37S
41. Wright C.D., Menard M.T., Wain J.C., Donahue D.M., Grillo H.C., Lynch T.J., et al. Induction chemoradiation compared with induction radiation for lung cancer involving the superior sulcus. Ann. Thorac. Surg. 73 (2002) 1541-1544